Throughout this medical market research, the publisher analyzed 37 soft tissue repair device companies in the US and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of the US Soft Tissue Repair market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes a soft tissue repair procedure volume analysis which can also be purchased as a separate report, MedPro.
Markets Covered
US Soft Tissue Repair Devices Market Insights
Soft tissue repair devices add significant costs to suture-based repair procedures. The cost varies, depending on the type of device used and the repair being performed, but, in general, biological devices, such as allografts and xenografts, cost significantly more than synthetic devices within the same market segment. For example, biological devices may offer superior long-term benefits in hernia repair by avoiding risks of infection and premature degradation and failure, but their high cost continues to deter surgeons from using them
The changing demographics in the U.S. has a very favorable effect on the soft tissue repair market. The growing elderly and obese populations have a higher risk of a number of different medical conditions, including hernias and nerve damage. Between 2010 and 2025, the total number of people with diabetes in the U.S. is expected to increase by 64%.
Overall, the U.S. soft tissue repair market was valued at $1.8 billion in 2019. This is expected to increase over the forecast period at a CAGR of 7.8% to reach $3.1 billion.
While this MedSuite report contains all of the US Soft Tissue Repair market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes a soft tissue repair procedure volume analysis which can also be purchased as a separate report, MedPro.
Markets Covered
- Soft Tissue Repair Procedure Volumes in the US– MedPro
- Breast Reconstruction Market - MedCore
- Hernia Repair Market - MedCore
- Dural Repair Market - MedCore
- Dental Soft Tissue Repair Market - MedCore
- Nerve Repair Market - MedCore
- Cardiovascular Repair Market - MedCore
US Soft Tissue Repair Devices Market Insights
Soft tissue repair devices add significant costs to suture-based repair procedures. The cost varies, depending on the type of device used and the repair being performed, but, in general, biological devices, such as allografts and xenografts, cost significantly more than synthetic devices within the same market segment. For example, biological devices may offer superior long-term benefits in hernia repair by avoiding risks of infection and premature degradation and failure, but their high cost continues to deter surgeons from using them
The changing demographics in the U.S. has a very favorable effect on the soft tissue repair market. The growing elderly and obese populations have a higher risk of a number of different medical conditions, including hernias and nerve damage. Between 2010 and 2025, the total number of people with diabetes in the U.S. is expected to increase by 64%.
Overall, the U.S. soft tissue repair market was valued at $1.8 billion in 2019. This is expected to increase over the forecast period at a CAGR of 7.8% to reach $3.1 billion.
Table of Contents
List of FiguresList of ChartsExecutive SummaryU.S. Soft Tissue Repair Market OverviewCompetitive AnalysisMarket TrendsMarket DevelopmentsProcedure NumbersMarkets IncludedKey Report UpdatesVersion HistoryAbbreviations
Research Methodology
U.S. Soft Tissue Repair Market Overview
Procedure Numbers
Breast Reconstruction Market
Hernia Repair Market
Dural Repair Market
Dental Soft Tissue Regeneration Market
Nerve Repair Market
Cardiovascular Repair Market
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- Ace Surgical
- ACell
- Admedus
- Aesculap
- Allergan
- AxoGen
- Baxter
- Becton Dickinson
- Citagenix
- Cook Medical
- CorMatrix
- Cryolife
- DePuy Synthes
- DynaMesh
- Edwards LifeSciences
- Ethicon
- Galatea Surgical
- Geistlich Pharma
- Getinge
- Gore
- Henry Schein
- Integra LifeSciences
- LeMaitre Vascular
- LifeNet Health
- Mast BioSurgery
- Medtronic
- MTF
- Natus Medical
- Novus Medical
- Osteogenics
- RTI Surgical
- Stryker
- TELA Bio
- Tissue Regenix
- Xtant Medical
- Zimmer Biomet
